Role of Amrutadi Kwatha in the management of Urdhwaga Amlapitta with special reference to Gastroesophageal reflux disease.

A randomized open labelled controlled clinical study to evaluate the efficacy of Amrutadi Kwatha in the management of Urdhwaga Amlapitta with special reference to Gastroesophageal reflux disease. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/080924

Enrollment

Registered

2025-02-19

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of either gender between age of 21-60 years. 2. Subjects freshly diagnosed with Urdhwaga Amlapitta (Gastroesophageal reflux disease) who are not on any interventions presenting the cardinal symptoms - Tikta amlodgara, Kantadaha, Hritdaha with or without associated symptoms like Klama, Gaurava, Avipaka, Aruchi, Chardi, Utklesha, Shiroruja. 3. Subjects who are willing to give informed written consent.

Exclusion criteria

Exclusion criteria: 1. Subjects diagnosed with Gastroesophageal reflux disease caused due to any other secondary conditions. 2. Subjects with diagnosed cases of erosive and post operative Gastroesophageal reflux disease. 3. Subjects suffering from any uncontrolled systemic disorders which will interfere with the course of disease and course of treatment. 4. Pregnant and Lactating women.

Design outcomes

Primary

Measure	Time frame
Changes in symptoms of Urdhwaga Amlapitta with special reference to Gastroesophageal reflux disease based on subjective parameters is assessed.Timepoint: 0th day - Before intervention 15th day - During intervention 30th day - After intervention 45th day - Drug free follow up	—

Secondary

Measure	Time frame
Generation of in depth analyzed data on the different aspects of the diseaseTimepoint: 0th day - Before intervention 15th day - During intervention 30th day - After intervention 45th day - Drug free follow up	—

Countries

India

Contacts

Public ContactDr Gopalakrishna G

Sri Sri College of Ayurvedic Science and Research Hospital, Bangalore

lakshmimp1981@gmail.com9448173128

Outcome results